Rifabutin is an antibiotic of the rifamycin class, which is particular
ly active against mycobacteria, including those that occur in AIDS pat
ients. Because clinical use will include long-term therapy, an extensi
ve battery of long-term toxicity studies was carried out by the oral r
oute, including carcinogenicity studies. An interesting feature was th
e occurrence of multinucleated hepatocytes (MNHs) in the rat. In some
instances, as many as 25 nuclei occurred in a single cell. Light micro
scopy revealed a large hepatocyte with normal eosinophilic staining. T
he multiple nuclei stained like those present in the surrounding norma
l cells. Electron microscopy showed no abnormalities of the nuclei and
no cell membranes within the cytoplasm. The customary organelles were
present. MNHs were dose- and sex-related, starting from 10 mg/kg/day
and being more evident in males. They began to appear after 5 wk of tr
eatment and persisted over long periods of recovery (12 mo), without s
howing any tendency for cell proliferation. The life-span of MNHs was
similar to that of normal hepatocytes. MNHs were present in the carcin
ogenicity study, but there was no increase in liver tumors. MNHs did n
ot occur in mice or monkeys treated with rifabutin, nor did they occur
in response to treatment with rifampin. The effect appears to be spec
ific to the rat.